July 12, 2014 6:05 AM ET

Biotechnology

Company Overview of Numerate, Inc.

Company Overview

Numerate, Inc., a biotechnology company, develops a drug engineering platform. Its drug engineering platform is used to design and develop small molecule therapeutics. The company’s drug engineering platform is also applied to various therapeutic programs, such as multi-targeted type 2 diabetes therapy and medicine for HIV. Numerate, Inc. was incorporated in 2007 and is based in San Bruno, California.

1150 Bayhill Drive

Suite 203

San Bruno, CA 94066

United States

Founded in 2007

Phone:

650-472-0632

Fax:

650-952-1927

Key Executives for Numerate, Inc.

Chief Executive Officer
Chief Scientific Officer and Principal Investigator of the Project
Head of Business Development
Age: 54
Chief Technology Officer
Senior Vice President of Business and Corporate Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Labrys Biologics, Inc. United States
Core Prognostex, Inc. United States
AuraZyme Pharmaceuticals, Inc. United States
CardioCreate, Inc. United States
CellzDirect, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 23, 2014
--
Private Placement
December 31, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Numerate, Inc., please visit www.numerate.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.